Clinical Trial Update: Dose Response to Topical Glyceryl Trinitrate in Patients With Raynaud's Phenomenon [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated the dose-response of topical glyceryl trinitrate in Raynaud's phenomenon. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Raynaud Phenomenon

Drugs mentioned

• Glyceryl Trinitrate (glyceryl trinitrate)

Snippet

Sponsor: Procris Pharmaceuticals | Conditions: Raynaud's Phenomenon | Phase 1 | Status: COMPLETED